Faculty profile

Richard Long

ResearcherMedicineUniversity of Alberta

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.

Richard Long

Researcher

Medicine

Health Sciences

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
20 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 10 research grants (8 CIHR, 2 SSHRC), most recently in 2024.
Supervised 4 trainees who won CIHR awards, most recently in 2011.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Tuberculosis Health Equity Population Health Indigenous Health Public Health Health Policy Communicable Disease Migrant Health

Latest papers

Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis.
The Lancet. Respiratory medicine · 2026
Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.
The Journal of infectious diseases · 2026
Increasing Innu participation in public health: a qualitative study of data governance among Innu in Labrador, Canada.
BMJ public health · 2026 · senior author

All 63 publications

Latest funding

Advancing tuberculosis elimination through stakeholder consultations to determine research priorities for people born outside of Canada
CIHR · 2024 · Nominated PI
$20,000
Evaluating a tuberculosis (TB) surveillance data dashboard in Alberta
SSHRC · 2021 · Principal investigator
$237,968
Implementing the 'Patients' Charter of Tuberculosis Care' in High Incidence Indigenous Communities and Across Jurisdictional Borders
CIHR · 2019 · Nominated PI
$1,500,000

All 14 grants and awards

63 publications.

Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis.

Linde LR, Campbell JI, Horsburgh CR, Fox MP, Abubakar I, Acuna-Villaorduna C, Alikhan F, Andrade BB, Arriaga MB, Balcells ME, Becerra MC, Benjumea-Bedoya D, Bennet R, Blumenfeld A, Bonnet M, Brewer TF, Carvalho ACC, Caylà JA, Chakhaia T, Chan PC, Chaw L, Chen C, Del Corral H, Dobler CC, Fang CT, Faridi MMA, Faye A, Graham SM, Gupta RK, Hauri AM, Heinmueller P, Hesseling A, Hill PC, Huang LM, Huerga H, Jones-López EC, Kinikar A, Kirchner HL, Kritski A, Lecca L, Lee MR, Lee CH, Lee LN, Liu Q, Long R, MacPherson P, Mandalakas A, Marin D, Martinson N, Mave V, Mazahir R, Murray M, Nejat S, Pasqualini C, Ruan Q, Rubinstein F, Ruiz-Tagle C, van der Loeff MFS, Seddon JA, Shah L, Sharma S, Shen Y, Srivastava G, Stein C, Triasih R, Trieu L, Verhagen LM, Villalba JA, Wang JY, Yuen C, Zhang W, Golub J, Martinez L

The Lancet. Respiratory medicine2026

DOI: 10.1016/s2213-2600(26)00219-5 PMID: 42759526

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Gafar F, Svensson EM, Yunivita V, Fregonese F, Fisher D, Fox GJ, Nguyen TA, Nguyen BH, Johnston J, Long R, Valiquette C, Aarnoutse RE, Ruslami R, Menzies D

The Journal of infectious diseases2026

DOI: 10.1093/infdis/jiag052 PMID: 41589392

Increasing Innu participation in public health: a qualitative study of data governance among Innu in Labrador, Canada.

Ward LM, Heffernan C, Alvarez GG, Picard A, Carrington A, Long R

BMJ public health2026Senior author

DOI: 10.1136/bmjph-2025-002745 PMID: 41835926

Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.

Romanowski K, Pham Ngoc Y, Barss L, Jabbour E, Johnston JC, Herman H, Long R, Apriani L, Fox G, Menzies D, Campbell JR

Open forum infectious diseases2025

DOI: 10.1093/ofid/ofaf563 PMID: 40980570

Lung structure and function, post-treatment, in strictly defined subclinical pulmonary tuberculosis: a prospective cohort study in Canada.

Long R, Collins S, Stickland MK, Kirby M, Lau A, Barrie J, Winter C, Armstrong G, Wong E, Parhar A, Yehya J, Bourbeau J, Tan WC, Doroshenko A

ERJ open research2025First author

DOI: 10.1183/23120541.01295-2024 PMID: 40661928

Refining the definition of miliary/disseminated tuberculosis in Canada.

Huang Y, Long R, Ferrara G, Egedahl ML, Doroshenko A, Heffernan C, Paulsen C, Cooper R, Lau A

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2024

DOI: 10.1016/j.ijid.2024.107238 PMID: 39260768

Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western Canada.

Riopel ND, Long R, Heffernan C, Tyrrell GJ, Shandro C, Li V, Islam MR, Stobart M, Sharma MK, Soualhine H, Cooper R

The Journal of infectious diseases2024

DOI: 10.1093/infdis/jiae124 PMID: 38456644

High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial.

Ruslami R, Fregonese F, Apriani L, Barss L, Bedingfield N, Chiang V, Cook VJ, Fisher D, Flores E, Fox GJ, Johnston J, Lim RK, Long R, Paulsen C, Nguyen TA, Nhung NV, Gibson D, Valiquette C, Benedetti A, Menzies D

The Lancet. Respiratory medicine2024

DOI: 10.1016/s2213-2600(24)00076-6 PMID: 38552659

Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trial.

Menzies D, Obeng J, Hadisoemarto P, Ruslami R, Adjobimey M, Fisher D, Barss L, Bedingfield N, Long R, Paulsen C, Johnston J, Romanowski K, Cook VJ, Fox GJ, Nguyen TA, Valiquette C, Oxlade O, Fregonese F, Benedetti A

EClinicalMedicine2024

DOI: 10.1016/j.eclinm.2024.102546 PMID: 38586588

The association between phylogenetic lineage and the subclinical phenotype of pulmonary tuberculosis: A retrospective 2-cohort study.

Long R, Croxen M, Lee R, Doroshenko A, Lau A, Asadi L, Heffernan C, Paulsen C, Egedahl ML, Lloyd C, Li V, Tyrrell G

The Journal of infection2024First author

DOI: 10.1016/j.jinf.2023.12.006 PMID: 38104727

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2024

Subject: Prospective PhD student: Tuberculosis Dear Professor Long, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Advancing tuberculosis elimination through stakeholder consultations to determine research priorities for people born outside of Canada" (2024), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Richard Long

Research

Latest papers

Latest funding

Duration of effectiveness of tuberculosis preventive treatment across various tuberculosis burden settings: a systematic review and individual-participant meta-analysis.

Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.

Increasing Innu participation in public health: a qualitative study of data governance among Innu in Labrador, Canada.

Costs of 4 Months of Rifampin Versus 2 Months of Double-dose Rifampin for Tuberculosis Infection: Post-Hoc Analysis of a Phase 2b Randomized Trial.

Lung structure and function, post-treatment, in strictly defined subclinical pulmonary tuberculosis: a prospective cohort study in Canada.

Refining the definition of miliary/disseminated tuberculosis in Canada.

Characterization of Mycobacterium orygis, Mycobacterium bovis, and Mycobacterium caprae Infections in Humans in Western Canada.

High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial.

Sustainability and impact of an intervention to improve initiation of tuberculosis preventive treatment: results from a follow-up study of the ACT4 randomized trial.

The association between phylogenetic lineage and the subclinical phenotype of pulmonary tuberculosis: A retrospective 2-cohort study.

Evaluating a tuberculosis (TB) surveillance data dashboard in Alberta

Pathways to Reconciliation: A Knowledge Exchange Forum or Dena' acla' nee' dale Focused on the History of Tuberculosis in Treaty 8

Frequent collaborators

Courtney Heffernan

Andrea Benedetti

Andrea Benedetti

James Johnston

Kevin Schwartzman

Gregory Tyrrell

Jody Boffa

Ambikaipakan Senthilselvan

Zhiwei Gao

Rovina Ruslami

Richard Long

Kamila Romanowski

Matthew Croxen

Kevin Schwartzman

Malcolm King

Janet Smylie

Sylvia Abonyi

Miranda Kirby

Miranda Kirby

Malcolm King

Janet Smylie

Billie-Jo Hardy

Erin Strumpf

Maria Mayan